Drug reference
secukinumab
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Miscellaneous (Monoclonal Antibodies)
Mechanism of action
Human IgG1 monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin 17A (IL-17A)
IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses and plays a key role in the pathogenesis of plaque psoriasis
Common side effects
- Rhinitis
- Infections
- Nasopharyngitis.
- Skin and subcutaneous tissue disorders: Eczematous eruptions (atopic dermatitis-like eruptions)
- Oral herpes
- Diarrhea
Contraindications
- Hypersensitivity
Related conditions
Frequently asked questions
What drug class is secukinumab?
secukinumab belongs to: Miscellaneous.
How does secukinumab work?
Human IgG1 monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin 17A (IL-17A) IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses and plays a key role in the pathogenesis of plaque psoriasis
What are the common side effects of secukinumab?
Rhinitis, Infections, Nasopharyngitis., Skin and subcutaneous tissue disorders: Eczematous eruptions (atopic dermatitis-like eruptions), Oral herpes, Diarrhea
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.